* It is based on the local time of Seoul, Korea. (UTC/GMT +9:00)
Your local timezone is likely Asia/Seoul (+09:00 KST)
-
20:00
20:00 ? 20:10 Your local time 08:00 PM, Aug 20 (+09:00)
Welcome Remarks
Ha Kyoung KIM
President
Asia Pacific Retinal Imaging Soceity
-
20:10
20:10 ? 20:50 Your local time 08:10 PM, Aug 20 (+09:00)
Session 1
Giuseppe QUERQUES
20:10 ~ 20:18
TBA
Judy E KIM
20:18 ~ 20:26
Oral vs. Intravenous Fluorescent Angiogram for the Patients with Prior History of Retinopathy of Prematurity
Wei-Chi WU
20:26 ~ 20:34
Intraoperative OCT assisted intrascleral fixation of intraocular lens
Makoto INOUE
20:34 ~ 20:42
How Optical Coherence Angiography Changes My Practice
Miho NOZAKI
20:42 ~ 20:50
Clinical Utility of Morphofunctional Correlation of Microperimetry and Optical Coherence Tomography
K. Balley FREUND
-
20:55
20:55 ? 21:35 Your local time 08:55 PM, Aug 20 (+09:00)
Session 2
Philip J. ROSENFELD
20:55 ~ 21:03
The CAM classification for macular atrophy
Giovanni STAURENGHI
21:03 ~ 21:11
Natural History of Incomplete RPE and Outer Retinal Atrophy (IRORA) with OCT Imaging Analysis
David SARRAF
21:11 ~ 21:19
Computational modelling for assessing OCT biomarkers of geographic atrophy growth
Eric Moult
21:19 ~ 21:27
TBA
Don Il HAM
21:27 ~ 21:35
Choriocapillaris and scotopic visual function in AMD
Srinivas SADDA
-
21:40
21:40 ? 21:45 Your local time 09:40 PM, Aug 20 (+09:00)
Break symposium (by NOVARTIS)
Ha Kyoung KIM / Hee Sung Yoon
-
21:50
21:50 ? 22:38 Your local time 09:50 PM, Aug 20 (+09:00)
Session 3
Judy E Kim
21:50 ~ 21:58
Proper quantification of choriocapillaris in OCT angiography
Ruikang (Ricky) WANG
21:58 ~ 22:06
The role of the choroid and choriocapillaris in the enlargement of geographic atrophy in AMD using SS-OCTA
Philip J. ROSENFELD
22:06 ~ 22:14
Subthreshold laser treatment for reticular pseudodrusen secondary to age-related macular degeneration: The PASCAL clinical trial
Giuseppe QUERQUES
22:14 ~ 22:22
Anti-VEGF treatment in young CRVO patients
Ling YEUNG
22:22 ~ 22:30
Macular capillary occlusion and macular edema, which is the major determinant of vision in BRVO?
Toshinori MURATA
22:30 ~ 22:38
Correlation between Macular Vessel Density and Number of Intravitreal Anti-VEGF agents for Macular Edema Associated with BRVO
Hiroko TERASAKI
-
22:43
22:43 ? 23:23 Your local time 10:43 PM, Aug 20 (+09:00)
Session 4
Srinivas SADDA
22:43 ~ 22:51
Enhance s cone syndrome : An Expanded Clinical Spectrum Lawrence Yannuzzi
22:51 ~ 22:59
TBA
Alexander J. Brucker
22:59 ~ 23:07
TBA
Se Woong KANG
23:07 ~ 23:15
TBA
Richard SPAIDE
-
23:15
23:15 ~ Your local time 11:15 PM, Aug 20 (+09:00)
Closing remark
Philip J. ROSENFELD
Bascom Palmer Eye Institute
한국어
English
